LIV-2012

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLIV-2012
Drug Alias Nameoval cell-derived factor mAb (LivTech)OCDF-2/OCDF-4/OCDF-5 mAb (LivTech)LIV-2012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLivTech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLivTech Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A